| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00275269 |
| P698 | PubMed publication ID | 6997121 |
| P2093 | author name string | R Ebert | |
| W Creutzfeldt | |||
| P2860 | cites work | Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats | Q28582244 |
| Duodenal endocrine cells in adult coeliac disease | Q34475666 | ||
| Release of motilin by oral and intravenous nutrients in man | Q34494296 | ||
| Identification and Actions of Gastric Inhibitory Polypeptide | Q35155165 | ||
| Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea | Q38861383 | ||
| The incretin concept today | Q39227026 | ||
| On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane | Q39468517 | ||
| Gut-hormone profile in coeliac disease | Q39539213 | ||
| Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance | Q39676765 | ||
| Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCI, or ingestion of a meal | Q41293190 | ||
| The effect of oral galactose on GIP and insulin secretion in man | Q41493858 | ||
| Insulin secretion and pancreatic exocrine function in patients with chronic pancreatitis | Q41735467 | ||
| The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects | Q44470034 | ||
| Radioimmunoassay for Gastric Inhibitory Polypeptide | Q47832586 | ||
| Gastric Inhibitory Polypeptide (GIP) Stimulated by Fat Ingestion in Man | Q51672945 | ||
| [On radio-immunologic determination of insulin in blood]. | Q54786649 | ||
| Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances | Q66898754 | ||
| Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro | Q66902005 | ||
| Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels | Q67275679 | ||
| Effects of Ingestion of Triglyceride or Galactose on Secretion of Gastric Inhibitory Polypeptide and on Responses to Intravenous Glucose in Normal and Diabetic Subjects | Q67317479 | ||
| Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man | Q67326950 | ||
| The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas | Q67785920 | ||
| Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy | Q67787089 | ||
| Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency | Q68211510 | ||
| Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man | Q68813361 | ||
| Plasma Gastrin Responses to Arginine in Chronic Pancreatitis | Q69341488 | ||
| Rapid gastric emptying of fatty meals in pancreatic insufficiency | Q69359794 | ||
| Stimulation of insulin secretion by gastric inhibitory polypeptide in man | Q69602585 | ||
| A radioimmunoassay for cholecystokinin-pancreozymin | Q70002075 | ||
| Comparison of different methods for the evaluation of the oral glucose tolerance test | Q71595702 | ||
| Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes | Q72125649 | ||
| Rapid method for the determination of fat in feces | Q80275926 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 198-204 | |
| P577 | publication date | 1980-09-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution | |
| P478 | volume | 19 |
| Q35858172 | Change of Both Endocrine and Exocrine Insufficiencies After Acute Pancreatitis in Non-Diabetic Patients: A Nationwide Population-Based Study |
| Q40129023 | Clinical aspects of GIP secretion |
| Q42022559 | Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis |
| Q27007060 | Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012 |
| Q43136282 | Determinants of glucose control in patients with chronic pancreatitis |
| Q27013787 | Diagnosis and treatment of diabetes mellitus in chronic pancreatitis |
| Q70265799 | Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs |
| Q57456150 | Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancrea |
| Q40814432 | Exocrine pancreatic insufficiency and diabetes mellitus |
| Q37913052 | Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? |
| Q47231163 | Functional and association analysis of an Amerindian-derived population-specific p.(Thr280Met) variant in RBPJL, a component of the PTF1 complex |
| Q70402111 | GIP and the metabolic response to carbohydrate and fat |
| Q57181851 | Glucose homeostasis dependency on acini-islet-acinar (AIA) axis communication: a new possible pathophysiological hypothesis regarding diabetes mellitus |
| Q37403983 | Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). |
| Q35858080 | Glycemic Change After Pancreaticoduodenectomy: A Population-Based Study. |
| Q35485201 | Gut hormones and diabetes mellitus |
| Q51606844 | Gut hormones and gastrointestinal motility in children with cystic fibrosis. |
| Q64889772 | Incidence of New Onset Diabetes Mellitus Secondary to Acute Pancreatitis: A Systematic Review and Meta-Analysis. |
| Q34407626 | Intraluminal gastric pH in chronic pancreatitis |
| Q98726633 | Islet cell dysfunction in patients with chronic pancreatitis |
| Q37811410 | K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease |
| Q28069386 | Management of pancreatogenic diabetes: challenges and solutions |
| Q28564632 | Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats |
| Q71562172 | Pancreatic islet-acinar interactions |
| Q51485588 | Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. |
| Q50981589 | Postprandial glucose-dependent insulinotropic polypeptide and insulin responses in patients with chronic pancreatitis with and without secondary diabetes. |
| Q45204627 | Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). |
| Q37653301 | Recurrent diabetic ketoacidosis: a rare presenting manifestation of primary hyperparathyroidism. |
| Q37206694 | Risk Factors for Diabetes Mellitus in Chronic Pancreatitis: A Cohort of 2,011 Patients |
| Q38894318 | The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis |
| Q40442511 | The pathology of islets in diabetes |
| Q34901533 | The role of incretins in glucose homeostasis and diabetes treatment |
| Q30234827 | Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer |
| Q85725459 | [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus] |
Search more.